Zydus Cadila gets DGCI nod for diabetes drug Saroglitazar Magnesium Farhat Nasim4 Feb 2020 5:00 AM GMT'Zydus Cadila has received the approval from the Drug Controller General of India (DCGI) for use of Saroglitazar Mg in the treatment of type II diabete...
DCGI releases list of Reference Products for conduct of BE Study, details Medical Dialogues Bureau25 Jan 2020 8:55 AM GMTNew Delhi: Through a recent notice, Drug Controller General of India has released the List of Products Permitted by DCG(I) and considered as Reference ...
Wockhardt gets DCGI nod for 2 new antibiotics Medical Dialogues Bureau17 Jan 2020 8:27 AM GMT 'DCGI has approved Wockhardts 2 new antibiotics, EMROK (IV) and EMROK O (Oral), for acute bacterial skin and skin structure Infections including diab...
CDSCO declares 450 FDCs as rational, issues directions for manufacturers Farhat Nasim15 Jan 2020 7:57 AM GMTNew Delhi: Apex drug regulator, Central Drugs Standard Control Organization (CDSCO) has recently declared 450 more Fixed-Dose Combination (FDC) Dr...
